Piotr Leszczyński

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study

Atul Deodhar, Alice B. Gottlieb, Wolf‐­Henning Boehncke et al. · The Lancet · 2018 · 184 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Successful eradication of methicillin-resistantStaphylococcus aureus (MRSA) intestinal carrier status in a healthcare worker — Case report

Piotr Leszczyński, Beata Weber‐Dąbrowska, M. Kohutnicka et al. · Folia Microbiologica · 2006 · 71 citations

Life Sciences, Infectious Diseases, Microbiology +17

Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility

Wojciech Pluskiewicz, Piotr Adamczyk, Edward Franek et al. · Bone · 2010 · 66 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Factors associated with quality of life in systemic sclerosis: a cross-sectional study

Matylda Sierakowska, Halina Doroszkiewicz, Justyna Sierakowska et al. · Quality of Life Research · 2019 · 53 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17